Patient and transplant characteristics
| Characteristic . | ECP, n = 48 . | Control, n = 47 . |
|---|---|---|
| Median age, y (range) | 41 (16-67) | 43 (13-67) |
| White race, n (%) | 45 (94) | 41 (87) |
| Males, n (%) | 30 (63) | 26 (55) |
| Primary disease, n (%) | ||
| Acute myeloid leukemia | 12 (25) | 9 (19) |
| Acute lymphoid leukemia | 6 (13) | 6 (13) |
| Chronic myeloid leukemia | 13 (27) | 16 (34) |
| Non-Hodgkin lymphoma | 2 (4) | 2 (4) |
| Others | 15 (31) | 14 (30) |
| Transplant cell source, n (%) | ||
| Bone marrow | 17 (35) | 15 (32) |
| Peripheral blood | 31 (65) | 32 (68) |
| HLA mismatch, n (%) | ||
| One locus | 5 (10) | 3 (6) |
| Two loci | 0 (0) | 3 (6) |
| Stem cell donors, n (%) | ||
| Related | 31 (65) | 34 (72) |
| Unrelated | 17 (35) | 13 (28) |
| Characteristic . | ECP, n = 48 . | Control, n = 47 . |
|---|---|---|
| Median age, y (range) | 41 (16-67) | 43 (13-67) |
| White race, n (%) | 45 (94) | 41 (87) |
| Males, n (%) | 30 (63) | 26 (55) |
| Primary disease, n (%) | ||
| Acute myeloid leukemia | 12 (25) | 9 (19) |
| Acute lymphoid leukemia | 6 (13) | 6 (13) |
| Chronic myeloid leukemia | 13 (27) | 16 (34) |
| Non-Hodgkin lymphoma | 2 (4) | 2 (4) |
| Others | 15 (31) | 14 (30) |
| Transplant cell source, n (%) | ||
| Bone marrow | 17 (35) | 15 (32) |
| Peripheral blood | 31 (65) | 32 (68) |
| HLA mismatch, n (%) | ||
| One locus | 5 (10) | 3 (6) |
| Two loci | 0 (0) | 3 (6) |
| Stem cell donors, n (%) | ||
| Related | 31 (65) | 34 (72) |
| Unrelated | 17 (35) | 13 (28) |